Skip to main content

Bank of New York Mellon Corp

Bank

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in TRDA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$581,954
-$382,553 QoQ
Shares Held
79,070
+3.5% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 128 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. TRDA ranks #231 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $581,954 79,070
2026-03-31 $964,507 76,427
2025-12-31 $815,974 79,375
2025-09-30 $613,674 105,806
2025-06-30 $658,747 98,028
2025-03-31 $904,542 100,060
2024-12-31 $1,752,479 101,358
2024-09-30 $1,677,372 104,967
2024-06-30 $1,787,462 125,436
2024-03-31 $1,567,173 110,598
2023-12-31 $1,736,254 115,060
2023-09-30 $1,057,856 66,953
2023-06-30 $1,005,098 66,387
2023-03-31 $180,365 12,439
2022-12-31 $168,175 12,439
2022-03-31 $205,950 21,933
2021-12-31 $233,806 13,657